UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                  SCHEDULE 13D

                    Under the Securities Exchange Act of 1934
                               (Amendment No. 3)*

                           Encore Capital Group, Inc.
                           --------------------------
                                (Name of Issuer)

                          Common Stock ($.01 par value)
                          -----------------------------
                         (Title of Class of Securities)

                                    292554102
                                   ----------
                                 (CUSIP Number)

                               John M. Allen, Esq.
                              Debevoise & Plimpton
                                919 Third Avenue

                               New York, NY 10022
               -------------------------------------------------
   (Name, Address and Telephone Number of Person Authorized to Receive Notices
                              and Communications)

                               September 25, 2003
                               -------------------
             (Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Section 240.13d-1(e), (f) or (g), check the following
box [ ].

Note: Schedules filed in paper format shall include a signed original and five
copies of the Schedule, including all exhibits. See Section 240.13d-7 for other
parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purposes of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).

CUSIP No. 292554102                13D



(1)  NAME OF REPORTING PERSON                     Robert Michael Whyte
     I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

--------------------------------------------------------------------------------
(2)  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP     (a)
                                                             ------------------
                                                          (b)
                                                             ------------------

--------------------------------------------------------------------------------
(3)  SEC USE ONLY

--------------------------------------------------------------------------------
(4)  SOURCE OF FUNDS                                      PF

--------------------------------------------------------------------------------
(5)  CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS      [ ]
     REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

--------------------------------------------------------------------------------
(6)      CITIZENSHIP OR PLACE OF ORGANIZATION             Australian

--------------------------------------------------------------------------------

Number of Shares         (7)  SOLE VOTING POWER           1,163,815
Beneficially Owned       -------------------------------------------------------
by Each Reporting        (8)  SHARED VOTING POWER         None
Person With              -------------------------------------------------------
                         (9)  SOLE DISPOSITIVE POWER      1,163,815
                         -------------------------------------------------------
                         (10) SHARED DISPOSITIVE POWER    None
--------------------------------------------------------------------------------
(11)  AGGREGATE AMOUNT BENEFICIALLY OWNED
      BY EACH REPORTING PERSON                            1,163,815

--------------------------------------------------------------------------------
(12)  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)
      EXCLUDES CERTAIN SHARES                             [ ]

--------------------------------------------------------------------------------
(13)  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  5.5%

--------------------------------------------------------------------------------
(14)  TYPE OF REPORTING PERSON                            IN

                                  Page 2 of 5

CUSIP No. 292554102                13D


                                  SCHEDULE 13D

                         Amendment No. 3 to Schedule 13D


            This Amendment No. 3 to Schedule 13D is filed by Robert Michael
Whyte ("Mr. Whyte") to further supplement and amend the Schedule 13D originally
filed by Mr. Whyte on March 4, 2002, as supplemented and amended by Amendment
No. 1, dated April 18, 2002 and Amendment No. 2, dated August 29, 2003 (the
"Schedule 13D"). Items 4, 5, 6, and 7 are hereby supplemented and amended.
Unless otherwise indicated, all capitalized terms shall have the same meaning as
provided in the Schedule 13D.

Item 4.     Purpose of Transaction.

            Item 4 is supplemented as follows:

            On September 25, 2003, the Company and the Reporting Persons entered
into an Underwriting Agreement pursuant to which the Company sold 3,000,000
shares of Common Stock and Mr. Whyte sold 120,285 shares of Common Stock to the
Underwriters for $10.34 a share. Mr. Whyte also granted the Underwriters an
over-allotment option to acquire up to an additional 62,918 shares of Common
Stock for the same price per share, exercisable at any time within 30 days of
the Closing, scheduled for October 1, 2003. In addition, as previously agreed,
the 100,000 shares of Series A Preferred Stock of Mr. Whyte are to be converted
into 1,000,000 shares of Common Stock at the Closing.

Item 5.     Interest in Securities of the Issuer.

            Item 5 is amended and supplemented as follows:

            (a) Following the sale to the Underwriters and the conversion of the
Series A Preferred Stock described in Item 4 (but prior to giving effect to
sales, if any, pursuant to the Underwriters over-allotment option), Mr. Whyte is
the beneficial owner of 1,163,815 shares of Common Stock, or approximately 5.5%
of the Company's outstanding shares of Common Stock (computed on the basis of
21,168,429 shares of Common Stock outstanding, as reported in the Company's Form
S-1 registration statement dated September 26, 2003).

            (b) Mr. Whyte has sole voting and dispositive power with respect to
the 1,163,815 shares of Common Stock.

            (c) Not applicable.

            (d) Not applicable.

            (e) Not applicable.

Item 6.     Contracts, Arrangements, Understandings or Relationships With
            Respect to Securities of the Issuer.

            Item 6 is supplemented as follows:

                                  Page 3 of 5

            See Item 4 for a description of the Underwriting Agreement, dated as
of September 25, 2003.

Item 7.     Materials to Be Filed as Exhibits.

            Item 7 is supplemented by adding the following:

Exhibit 9   Underwriting Agreement, dated as of September 25, 2003.

                                  Page 4 of 5

CUSIP No. 292554102                13D


                                    SIGNATURE

            After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement with respect to the
undersigned is true, complete and correct.

Date:  September 26, 2003

                              Robert Michael Whyte

                              By  /s/ Robert Michael Whyte
                                  ---------------------------------------------

                                  Page 5 of 5